The Cystic Fibrosis Foundation awarded up to $4.7 million to EnBiotix Inc. to study the potential use of inhaled colistin as an additional option to treat Pseudomonas infections in people with cystic fibrosis who are not responding to current treatments.
Site Search
Showing 1 - 10 of 13 results
News
|
Jan. 4, 2022
|
2 min read
The Cystic Fibrosis Foundation awarded up to $3.5 million to Arrevus Inc. to test a potential treatment for pulmonary exacerbations in people with cystic fibrosis in a late phase clinical trial.
News
|
Jan. 6, 2022
|
1 min read
Results show that people on Trikafta® enrolled in the six-week study were able to safely stop taking one of the two common CF medications without negatively affecting their health.
News
|
Nov. 4, 2022
|
4 min read
Bill will jump-start rebuilding of the antibiotics pipeline that is vital to stave off a looming pandemic.
News
|
Nov. 16, 2022
|
3 min read
Vertex’s copay assistance changes add an undue burden for people living with an already expensive, challenging lifelong disease.
News
|
Nov. 23, 2022
|
3 min read
Lee University